Drawing for SUMITOMO DAINIPPON PHARMA

USPTO serial 79158646

SUMITOMO DAINIPPON PHARMA

Reviewed by CopyMark Law Group

Reg. 4848567Status 404
Filing date
Status date
Registration date
Nov 10, 2015
Examiner
BHANOT, KAPIL KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUMITOMO DAINIPPON PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan Wenderoth LLP1025 Connecticut Ave., N.W., Suite 500Washington, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, both prescription and over-the-counter, namely, preparations for use in treating the central nervous system for use in connection with humans and animals; pharmaceutical preparations for use in treating the peripheral nervous system for use in connection with humans and animals; pharmaceutical preparations for use in treating sensory organs for use in connection with humans and animals; pharmaceutical preparations for use in treating respiratory organs for use in connection with humans and animals; pharmaceutical preparations for use in treating metabolism for use in connection with humans and animals; pharmaceutical preparations for use in treating epidermis for use in connection with humans and animals; pharmaceutical preparations for use in treating uro-genitial organs for use in connection with humans and animals; pharmaceutical preparations for use in treating digestive organs for use in connection with humans and animals; pharmaceutical preparations for use in treating cardiovascular organs for use in connection with humans and animals; antiallergic pharmaceutical preparations for use in connection with humans and animals; diagnostic pharmaceutical preparations for medical and veterinary use; antitumor pharmaceutical preparations for use in connection with humans and animals; antibiotic pharmaceutical preparations for use in connection with humans and animals; chemotherapeutic pharmaceutical preparations for use in connection with humans and animals; biological pharmaceutical preparations for the treatment of cancer for use in connection with humans and animals; immunoregulator pharmaceutical preparations for use in connection with humans and animals; pharmaceutical preparations, namely, chemical reagents for medical or veterinary purposes; diagnostic pharmaceutical preparations for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 13, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 4, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 15, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 15, 2023INPCINVALIDATION PROCESSED—
Jan 27, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 23, 2023CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 11, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 23, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 27, 2022C71TCANCELLED SECTION 71—
Nov 10, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 5, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 27, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 11, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 11, 2016FIMPFINAL DISPOSITION PROCESSED—
Feb 10, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 10, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 6, 2015CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Aug 5, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 5, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 5, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 4, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 4, 2015EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 23, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 22, 2015ALIEASSIGNED TO LIE—
Jul 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jul 10, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 10, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 10, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 26, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 27, 2015RFNTREFUSAL PROCESSED BY IB—
Mar 9, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 9, 2015RFRRREFUSAL PROCESSED BY MPU—
Mar 6, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 5, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2015DOCKASSIGNED TO EXAMINER—
Jan 20, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 16, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 15, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance